Skip to content

Rapid sequence emergence of general Anaesthesia

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516415-24-03
Enrollment
10
Registered
2025-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia

Brief summary

Time to the return of spontaneous breathing

Detailed description

Time to opening the eyes, Time to return of airway reflexes (swallow-ing, coughing), Respiratory effects (saturation, respiratory rate, capnography), Hemodynamic effects (blood pressure, heart rate), Bispectral Index Score (BIS), Neuromuscular block depth, Physician satisfaction, Total time to emerge from anaesthesia (to-tally awake, as before induction)

Interventions

DRUGSugammadex hameln 100 mg/ml oplossing voor injectie
DRUGNaloxon HCl Accord 0
DRUGoplossing voor injectie / infusie in een voorgevulde spuit
DRUGANEXATE 0
DRUG5 mg/5 ml
DRUGsolution injectable (I.V.)
DRUGREMIMAZOLAM
DRUGSufentanil Viatris 5 microgram/ml oplossing voor injectie
DRUGEsmeron 10 mg/ml
DRUGoplossing voor injectie

Sponsors

Stichting Radboud universitair medisch centrum
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Time to the return of spontaneous breathing

Secondary

MeasureTime frame
Time to opening the eyes, Time to return of airway reflexes (swallow-ing, coughing), Respiratory effects (saturation, respiratory rate, capnography), Hemodynamic effects (blood pressure, heart rate), Bispectral Index Score (BIS), Neuromuscular block depth, Physician satisfaction, Total time to emerge from anaesthesia (to-tally awake, as before induction)

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026